Skip to main content

Alzheimer's Disease Prevention - Extended Youthfulness

  • Synopsis: Published: 2009-12-10 (Revised/Updated 2016-06-13) - There is something about being youthful that protects us from Alzheimers disease - Cell Press.

Main Document

Quote: "The new findings confirm an earlier report by the Salk team in worms engineered to produce the human beta amyloid protein in their body wall muscles."

Therapies that can keep us younger longer might also push back the clock on Alzheimer's disease, suggests a new study of mice in the December 11th issue of the journal Cell, a Cell Press publication.

"There's something about being youthful that protects us from Alzheimer's disease," said Andrew Dillin of The Salk Institute for Biological Studies. "People say that if you live long enough, you get Alzheimer's. But if that were true, mice that live longer should get the disease at the same rate. That's not what we found."

The researchers show that mice carrying human genes that cause them to develop Alzheimer's can be protected from that disease by turning down a pathway that is well known for its effects on aging. Surprisingly, the brains of the mice who were spared the cognitive, inflammatory and neural effects of Alzheimer's by reducing the so-called insulin/IGF signaling pathway were still riddled with amyloid plaques. However, those plaques were more tightly packed into larger clusters than they would otherwise have been.

"We expected to see less plaque in the protected mice," Dillin said. "Instead we saw the same number of plaques, but there was a qualitative difference in how they looked. They were condensed so that they took up less area in the brain." Those larger structures are apparently also less toxic.

The new findings confirm an earlier report by the Salk team in worms engineered to produce the human beta amyloid protein in their body wall muscles.

Dillin said they don't yet completely understand how the lowered IGF signal protects the mice, but the pathway is known to negatively control two transcription factors (FOXO and HSF-1). Those transcription factors in turn control other genes encoding molecular chaperones, whose job it is to protect all of a cell's proteins.

"To maintain youth, you have to protect the proteome, not just the genome," he said. That may be particularly critical in long-lived cells like neurons, heart and muscle, which do not often divide and replace themselves. He points out that those who are genetically predisposed to develop early onset Alzheimer's carry the gene their whole lives, but don't develop the disease until they reach their 50s.

He thinks that youth-extending drugs aimed at increasing the activity of the FOXO and HSF-1 transcription factors may be the better bet for staving off Alzheimer's disease since the IGF pathway plays so many varied roles in the body. He plans to test in further studies whether a similar mechanism can also yield benefits for other neurodegenerative diseases that tend to come on with age, including Parkinson's and Huntington's diseases.

Dillin emphasizes that the ultimate aim is to improve the quality of life, not the quantity. "The goal is not to make people live to be 250 years old; it is to delay the onset of sickness," he said. "I want to find ways to extend health span, not necessarily life span."

The researchers include:

Ehud Cohen, Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA, The Hebrew University Medical School, Jerusalem, Israel; Johan F. Paulsson, The Scripps Research Institute, La Jolla, CA; Pablo Blinder, University of California, San Diego, La Jolla, CA; Tal Burstyn-Cohen, University of California, San Diego, La Jolla, CA; Deguo Du, The Scripps Research Institute, La Jolla, CA; Gabriela Estepa, Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA; Anthony Adame, University of California, San Diego, La Jolla, CA; Hang M. Pham, University of California, San Diego, La Jolla, CA; Martin Holzenberger, INSERM and Universite Pierre-et-Marie-Curie, UMRS 938, Hopital Saint-Antoine, Paris, France; Jeffery W. Kelly, The Scripps Research Institute, La Jolla, CA; Eliezer Masliah, University of California, San Diego, La Jolla, CA; and Andrew Dillin, Howard Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA.



Information from our Alzheimer's Disease: Facts & Research Information section - (Full List).

Submit event details, disability news, and assistive technology products for publishing on Disabled World


Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


Blood Pressure Chart - What should your blood pressure be. Also see information on blood group types and compatibility.



  1. Social Networking Helps Keep People Healthy
  2. Majority in Favor of Spinal Muscular Atrophy (SMA) Screening
  3. When the Spinal Cord Takes Charge of Information Related to Movement
  4. Sign Language Comparative List of Astronomical Words




Citation



Errors: Disabled World is an independent website, your assistance in reporting outdated or inaccurate information is appreciated. If you find an error please let us know.

Disclaimer: Content on Disabled World is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. See our Terms of Service for more information.